Scientific Advisory Committee

Scientific Advisory Committee

Dr Philip Pizzo (Chair)

Stanford University, USA

Dr Philip Pizzo.jpgProfile: Philip A. Pizzo became dean of the Stanford School of Medicine in 2001. Before that, he was the physician-in-chief of Children’s Hospital in Boston and chair of the Department of Pediatrics at Harvard Medical School. Pizzo received his BS from Fordham University and an MD from the University of Rochester School of Medicine. He completed an internship and residency at Children’s Hospital Medical Center in Boston, a teaching fellowship at Harvard Medical School, and a clinical and research fellowship in pediatric oncology at the National Cancer Institute. In 1988 Pizzo published the first article in the New England Journal of Medicine on antiviral therapy of HIV in children. He is the author of more than 500 scientific articles and 14 books. Pizzo has received several awards from the U.S. Public Health Service, including the Outstanding Service Medal in 1995. In 1997 he was elected to membership in the Institute of Medicine of the National Academy of Sciences.

Dr Faleh Mohamed Husain Ali

Supreme Council of Health, Qatar

Dr Faleh Mohamed Husain Ali.jpgProfile: Dr Faleh Mohamed Hussain Ali is Assistant Secretary General for Policy Affairs of the Supreme Council of Health (SCH) of Qatar. He leads the SCH Directorate General for Policy Affairs, one of three SCH Directorates. The departments reporting to him are Health Planning and Assessment, Health Financing and Insurance, IT and E‐Health Strategy, Medical Licensing, Quality Management, Medical Research, the National Health Strategy 2011‐2016 Project Management Office. He is a Visiting Lecturer at Imperial College London, where he lectures Masters of Science Degree students in Health Policy. Prior to turning to administration about ten years ago, Dr Faleh worked as an orthopedic surgeon and an emergency physician. He graduated from the Royal College of Surgeons in Dublin, Ireland, in 1993. Furthermore, Dr Faleh holds a Master of Science Degree in Health Management from the Tanaka Business School, Imperial College London.

Professor Sir Martin Evans

Cardiff University, UK

Professor Sir Martin Evans.jpgProfile: Professor Sir Martin Evans gained his BA in Biochemistry from Christ College, University of Cambridge in 1963 and his PhD from University College, London. His early PhD research led him to explore the use of cultures of mouse teratocarcinoma stem cells in tissue culture systems. In 1981 he was able to isolate similar cells from normal mouse embryos. These cells became known as "Embryonic Stem Cells“ and form the basis of all mouse knockout and targeted genetic manipulation. In 2007 Professor Sir Martin received the Nobel Prize for Medicine. He has published more than 120 scientific papers. He was elected a Fellow of the Royal Society in 1993 and is a founder Fellow of the Academy of Medical Sciences. In 1993 he was awarded the Walter Cottman Fellowship and the William Bate Hardy Prizes. He was knighted in 2004 and in 2009 was awarded the Gold Medal of The Royal Society of Medicine in recognition of his valuable contribution to medicine.

Dr Javaid Sheikh

Weill Cornell Medical College in Qatar

Dr Javaid Sheikh.jpgProfile: Javaid I. Sheikh, MD, was appointed as Dean at Weill Cornell Medical College in Qatar (WCMC-Q) in 2010. Dr Sheikh joined WCMC-Q as Vice Dean for Research and Professor of Psychiatry in early 2007 from Stanford University School of Medicine, where he was an Associate Dean and Professor of Psychiatry and Behavioral Sciences. From 2001-2006, Dr Sheikh served as Associate Dean for Veterans Affairs at Stanford and the Chief of Medical Staff at the Stanford affiliate VA Palo Alto Health Care System (VAPAHCS). Dr Sheikh is a graduate of King Edward Medical College, Lahore, Pakistan who started his psychiatry residency training at University of Connecticut and completed it at Stanford University School of Medicine. He is an internationally renowned researcher in the area of anxiety disorders. Most recently, his group is investigating biomarkers and risk factors associated with perinatal depression. He has published around 140 scientific articles.

Dr Moncef Slaoui

GlaxoSmithKline, PLC, USA

Dr Moncef Slaoui.jpgProfile: Moncef Slaoui has been Chairman, Research & Development of GlaxoSmithKline, PLC, since June 2006, with overall responsibility for GSK Vaccines and Oncology businesses. He has spearheaded an overhaul of GSK’s pharmaceutical R&D, resulting in a substantial improvement in productivity. In his previous position in GSK, he engineered the development of a robust vaccines pipeline, including Rotarix, to prevent infantile gastroenteritis; Synflorix, to prevent Pneumococcal disease; Cervarix, to prevent cervical cancer; and Mosquirix, to prevent Childhood Malaria. Dr Slaoui earned a PhD in molecular biology and immunology from the Université Libre de Bruxelles, Belgium, and completed postdoctoral studies at Harvard Medical School and Tufts University School of Medicine, Boston. He was a professor of immunology at the University of Mons, Belgium. He has authored more than 100 scientific papers and presentations and is a Member of the PhRMA Board of Directors.

Dr Judith L. Swain

Singapore Institute for Clinical Sciences, A*STAR

Dr Judith L. Swain.jpgProfile: Judith L. Swain, MD received her BS from the University of California, Los Angeles and her MD from the University of California, San Diego. Dr Swain served as chair of the Department of Medicine at Stanford University from 1997 to 2005, and previously served on the medical faculties of the University of Pennsylvania and Duke University. From 2005 to 2006, she was the dean for translational medicine at the University of California, San Diego. In 2007 Dr Swain became the executive director of the Singapore Institute for Clinical Sciences within A*STAR, and the Lien Chow Professor of Medicine at the National University of Singapore. She is currently a director of the Burroughs Wellcome Fund and a member of the Council of the Institute of Medicine, National Academies of Science. She has served as a director or member of the scientific advisory boards for a number of biomedical technology companies and is co-founder of Synecor, LLC).

Back to Top